|
|
 |
|
Total Number of Holdings (excluding cash): 51
| Teleflex Incorporated |
TFX |
879369106 |
326 |
$45,252.06 |
2.32% |
| Shanghai Microport Medbot (Group) Co., Ltd. (Class H) |
2252.HK |
Y768JD106 |
10,500 |
$44,635.79 |
2.29% |
| Align Technology, Inc. |
ALGN |
016255101 |
223 |
$43,719.15 |
2.24% |
| Bio-Rad Laboratories, Inc. (Class A) |
BIO |
090572207 |
138 |
$41,507.64 |
2.13% |
| Intuitive Surgical, Inc. |
ISRG |
46120E602 |
86 |
$41,591.32 |
2.13% |
| Sartorius Stedim Biotech |
DIM.FP |
F8005V210 |
193 |
$41,566.58 |
2.13% |
| Demant A/S |
DEMANT.DC |
K3008M105 |
1,240 |
$41,369.91 |
2.12% |
| Baxter International Inc. |
BAX |
071813109 |
2,250 |
$41,197.50 |
2.11% |
| Carl Zeiss Meditec AG (Bearer) |
AFX.GY |
D14895102 |
1,268 |
$41,171.33 |
2.11% |
| West Pharmaceutical Services, Inc. |
WST |
955306105 |
150 |
$41,161.50 |
2.11% |
| Boston Scientific Corporation |
BSX |
101137107 |
624 |
$40,478.88 |
2.08% |
| Globus Medical, Inc. (Class A) |
GMED |
379577208 |
427 |
$40,565.00 |
2.08% |
| Revvity, Inc. |
RVTY |
714046109 |
430 |
$40,540.40 |
2.08% |
| Straumann Holding AG (Registered) |
STMN.SW |
H8300N127 |
361 |
$40,473.96 |
2.08% |
| Agilent Technologies, Inc. |
A |
00846U101 |
335 |
$40,357.45 |
2.07% |
| Edwards Lifesciences Corporation |
EW |
28176E108 |
495 |
$40,357.35 |
2.07% |
| Waters Corporation |
WAT |
941848103 |
121 |
$40,459.98 |
2.07% |
| LivaNova Plc |
LIVN |
G5509L101 |
615 |
$40,085.70 |
2.06% |
| Thermo Fisher Scientific Inc. |
TMO |
883556102 |
78 |
$40,090.44 |
2.06% |
| Merit Medical Systems, Inc. |
MMSI |
589889104 |
565 |
$39,391.80 |
2.02% |
| Sysmex Corporation |
6869.JP |
J7864H102 |
4,434 |
$39,184.85 |
2.01% |
| Becton, Dickinson and Company |
BDX |
075887109 |
250 |
$38,912.50 |
2.00% |
| Penumbra, Inc. |
PEN |
70975L107 |
117 |
$38,868.57 |
1.99% |
| Masimo Corporation |
MASI |
574795100 |
216 |
$38,562.48 |
1.98% |
| Steris Plc |
STE |
G8473T100 |
173 |
$38,674.15 |
1.98% |
| Zimmer Biomet Holdings, Inc. |
ZBH |
98956P102 |
414 |
$38,518.56 |
1.98% |
| Koninklijke Philips N.V. |
PHIA.NA |
N7637U112 |
1,355 |
$38,381.66 |
1.97% |
| Olympus Corporation |
7733.JP |
J61240107 |
3,940 |
$38,498.65 |
1.97% |
| DexCom, Inc. |
DXCM |
252131107 |
603 |
$38,236.23 |
1.96% |
| Sonova Holding AG (Registered) |
SOON.SW |
H8024W106 |
167 |
$38,276.58 |
1.96% |
| Alcon Inc. |
ALC.SW |
H01301128 |
494 |
$38,014.52 |
1.95% |
| Coloplast A/S (Class B) |
COLOB.DC |
K16018192 |
574 |
$38,066.78 |
1.95% |
| Insulet Corporation |
PODD |
45784P101 |
196 |
$37,949.52 |
1.95% |
| LeMaitre Vascular, Inc. |
LMAT |
525558201 |
337 |
$38,013.60 |
1.95% |
| Mettler-Toledo International Inc. |
MTD |
592688105 |
29 |
$37,992.03 |
1.95% |
| BioMerieux |
BIM.FP |
F1149Y232 |
365 |
$37,916.69 |
1.94% |
| Fisher & Paykel Healthcare Corporation Limited |
FPH.NZ |
Q38992105 |
1,711 |
$37,739.54 |
1.94% |
| Terumo Corporation |
4543.JP |
J83173104 |
2,860 |
$37,867.45 |
1.94% |
| GE HealthCare Technologies Inc. |
GEHC |
36266G107 |
527 |
$37,617.26 |
1.93% |
| Siemens Healthineers AG |
SHL.GY |
D6T479107 |
871 |
$37,588.98 |
1.93% |
| Smith & Nephew Plc |
SN/.LN |
G82343164 |
2,299 |
$37,703.57 |
1.93% |
| Stryker Corporation |
SYK |
863667101 |
114 |
$37,545.90 |
1.93% |
| Danaher Corporation |
DHR |
235851102 |
203 |
$37,360.12 |
1.92% |
| ResMed Inc. |
RMD |
761152107 |
169 |
$37,524.76 |
1.92% |
| Medtronic Plc |
MDT |
G5960L103 |
442 |
$36,783.24 |
1.89% |
| The Cooper Companies, Inc. |
COO |
216648501 |
542 |
$36,270.64 |
1.86% |
| WuXi AppTec Co., Ltd. (Class H) |
2359.HK |
Y971B1118 |
2,285 |
$35,558.19 |
1.82% |
| Abbott Laboratories |
ABT |
002824100 |
385 |
$35,304.50 |
1.81% |
| Hoya Corporation |
7741.JP |
J22848105 |
194 |
$34,866.50 |
1.79% |
| Cochlear Limited |
COH.AU |
Q25953102 |
317 |
$22,598.80 |
1.16% |
| US Dollar |
$USD |
|
7,240 |
$7,239.87 |
0.37% |
| Swiss Franc |
$CHF |
|
361 |
$459.99 |
0.02% |
| Euro |
$EUR |
|
0 |
$0.06 |
0.00% |
| Pound Sterling |
$GBP |
|
0 |
$0.15 |
0.00% |
| TPG Inc. (CVR) |
2602335D |
436CVR021 |
612 |
$0.00 |
0.00% |
Holdings are subject to change.
The holdings information set forth above for the date indicated reflects creation and redemption transactions from the prior business day and may differ from the holdings information currently available from the Fund's custodian and accounting agent. With respect to the market value of the Fund's holdings set forth above, the pricing sources are generally third party vendors. The Fund ultimately relies on pricing information provided by the Fund's accounting agent.
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|